Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ProPhase Labs, Inc. PRPH NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
34/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.00
+9214.7%

ProPhase Labs, Inc. (PRPH) has 12 identified peers for comparison in the Healthcare sector. Peers include BDSX, BNR, DRIO, ENZ, GTH, INBS and others.

PRPH has a market capitalization of $711.97K, compared to an average peer market cap of $689.69M. PRPH is notably smaller than its average peer.

People Also View

SHC
SHC
Sotera Health Company
$16.03
+0.63%
 OLK
OLK
Olink Holding AB (publ)
$26.08
+0.31%
 GTH
GTH
Genetron Holdings Limited
$4.03
+0.12%
 STIM
STIM
Neuronetics, Inc.
$1.39
-2.80%
 BDSX
BDSX
Biodesix, Inc.
$12.66
+4.28%
 SERA
SERA
Sera Prognostics, Inc.
$2.18
+1.87%
 XGN
XGN
Exagen Inc.
$3.07
+0.99%
 DRIO
DRIO
DarioHealth Corp.
$7.51
-0.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message